beyond spring pharma stock

The Companyâs lead product Plinabulin which is being studied as an anti-cancer agent in combination with docetaxel in advanced non-small cell lung. They recently received or are about to receive 30mn in upfront payment.

Circling Back On Beyondspring Bysi Stock Seeking Alpha

BYSI stock are taking off on Wednesday following an important update regarding the firms lung cancer treatment.

. BeyondSpring Announces Fourth Quarter and Year End 2021 Financial Results and Provides a Corporate Update. Shares of BeyondSpring BYSI -362 soared on Wednesday after the pharmaceutical company released promising clinical trial results for its investigational lung cancer treatment. Ad Buy these 10 high-yield stocks today to start generating a reliable source of income.

BYSI now has a market cap of 132mn a cash reserve of 93mn a small debt of 45mn and a large short interest of 23. BYSI stock price quote stock graph news analysis. By the close of.

- Company to host call today April 14 2022 at 800 am ET - Conference call can be accessed by dialing 877-451-6152 US. The pharmaceutical company announced that its. Find the latest BeyondSpring Inc.

It had slid 27 in the six months through Tuesday. Events presentations. Ad These 3 almost-unknown healthcare stocks are potentially breakout stars at a bargain price.

BeyondSpring is a global clinical-stage bio-pharmaceutical company developing innovative immuno-oncology cancer therapies with a robust pipeline from internal development and from collaboration with the University of Washington in de novo drug discovery using a. BeyondSpring Pharmaceuticals Inc NASDAQBYSI shared the. The passcode is 13728822.

If youre experienced in therapeutics share our spirit for improving patients lives or are looking for an exciting opportunity with an innovative and solidly growing company wed like to meet you. The post-pandemic biotech revolution could be a ground-floor opportunity for investors. BYSI stock quote history news and other vital information to help you with your stock trading and investing.

According to the issued ratings of 6 analysts in the last year the consensus rating for BeyondSpring stock is Hold based on the current 1 sell rating 3 hold ratings and 2 buy ratings for BYSI. And Canada or 1-201-389-0879 International. Food and Drug.

Learn more on BYSIs analyst rating history. Why Are BeyondSprings Shares Plunging Today. The 10 High-Yielding Dividend Stocks To Own Today.

Real time BeyondSpring Inc. The live webcast can be accessed here or. 20 2021 0222 PM.

Shares of BeyondSpring NASDAQ. Is a clinical-stage global biopharmaceutical company. The Company is focused on developing cancer therapies to improve clinical outcomes for patients who have high unmet medical needs.

The average twelve-month price prediction for BeyondSpring is 3000 with a high price target of 6500 and a low price target of 500. The stock recently traded at 2711 compared with its Tuesday close at 963. BeyondSpring now will take its case to the US.

Discover our most recent and upcoming events as well as download informative presentationsall right here.

Stock Overview Beyondspring

Beyondspring Inc Bysi Stock 10 Year History

Circling Back On Beyondspring Bysi Stock Seeking Alpha

Beyondspring S Plinabulin Upcoming Pdufa And Positioning In The Cin Space Nasdaq Bysi Seeking Alpha

Bysi Institutional Ownership And Shareholders Beyondspring Inc Nasdaq Stock

Why Beyondspring Stock Skyrocketed Today The Motley Fool

Circling Back On Beyondspring Bysi Stock Seeking Alpha

Beyondspring Bysi Stock Why The Price Substantially Fell Today

Beyondspring Stock Lack Of Transparency Creates Downside Risk Nasdaq Bysi Seeking Alpha

Foreign Issuer Report 6 K

Beyondspring Bysi Market Capitalization

Beyondspring Pharmaceuticals Receives Complete Response Letter From The Fda For Plinabulin New Drug Application For Prevention Of Chemotherapy Induced Neutropenia Cin